These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Treatment of acute neuroleptic-induced movement disorders. Tonda ME; Guthrie SK Pharmacotherapy; 1994; 14(5):543-60. PubMed ID: 7997388 [TBL] [Abstract][Full Text] [Related]
5. Amantadine in the management of extrapyramidal side effects. Borison RL Clin Neuropharmacol; 1983; 6 Suppl 1():S57-63. PubMed ID: 6139167 [No Abstract] [Full Text] [Related]
6. [Extrapyramidal movement disorders arising during treatment of psychoses with drugs]. Vatsek Ia Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(3):453-7. PubMed ID: 4940 [No Abstract] [Full Text] [Related]
7. Extrapyramidal side effects of antipsychotic medications. Harris E Am J Nurs; 1981 Jul; 81(7):1324-8. PubMed ID: 6113762 [No Abstract] [Full Text] [Related]
8. Four oral motor disorders: bruxism, dystonia, dyskinesia and drug-induced dystonic extrapyramidal reactions. Clark GT; Ram S Dent Clin North Am; 2007 Jan; 51(1):225-43, viii-ix. PubMed ID: 17185068 [TBL] [Abstract][Full Text] [Related]
9. Clinical nonrecognition of neuroleptic-induced movement disorders: a cautionary study. Weiden PJ; Mann JJ; Haas G; Mattson M; Frances A Am J Psychiatry; 1987 Sep; 144(9):1148-53. PubMed ID: 2888321 [TBL] [Abstract][Full Text] [Related]
10. Treating extrapyramidal reactions: some current issues. Gelenberg AJ J Clin Psychiatry; 1987 Sep; 48 Suppl():24-7. PubMed ID: 2887554 [TBL] [Abstract][Full Text] [Related]